Ignite Creation Date:
2025-12-25 @ 5:18 AM
Ignite Modification Date:
2025-12-26 @ 4:26 AM
Study NCT ID:
NCT06225427
Status:
RECRUITING
Last Update Posted:
2025-10-17
First Post:
2024-01-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Gilteritinib for the Treatment of ALK NSCLC
Sponsor:
University of Michigan Rogel Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-25
Start Date Type:
ACTUAL
Primary Completion Date:
2027-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-05
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-13
First Submit QC Date:
None
Study First Post Date:
2024-01-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-15
Last Update Post Date:
2025-10-17
Last Update Post Date Type:
ESTIMATED